DWA
AVXL icon

Dorsey Wright & Associates’s Anavex Life Sciences AVXL Stock Holding History

Dorsey Wright & Associates’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,361
Closed -$12K – 308
2020
Q2 		$12K Buy
+2,361
New +$8.92K ﹤0.01% 201

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dorsey Wright & Associates's AVXL Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Anavex Life Sciences (AVXL) in Q3 2020, closing a stake of 2,361 shares — an estimated $12K sold.

Dorsey Wright & Associates first reported a position in AVXL in Q2 2020 and held it in 1 quarter. The position peaked at $12K in Q2 2020. 78 funds tracked by Wall St. Rank hold AVXL as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Anavex Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,361 Anavex Life Sciences shares in Q3 2020, an estimated $12K.
  • Dorsey Wright & Associates first reported a position in Anavex Life Sciences in Q2 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Anavex Life Sciences position peaked at $12K in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.